EMG
BIIB icon

ETF Managers Group’s Biogen BIIB Stock Holding History

ETF Managers Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,034
Closed -$563K – 692
2022
Q4 		$563K Buy
+2,034
New +$574K 0.03% 325
2022
Q2 		– Sell
-2,484
Closed -$524K – 772
2022
Q1 		$524K Buy
2,484
+45
+2% +$9.79K 0.01% 469
2021
Q4 		$585K Buy
2,439
+114
+5% +$29.3K 0.01% 487
2021
Q3 		$664K Buy
2,325
+178
+8% +$58.3K 0.01% 424
2021
Q2 		$742K Buy
+2,147
New +$650K 0.01% 309

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ETF Managers Group's BIIB Position: Q1 2023 in Review

ETF Managers Group sold out of Biogen (BIIB) in Q1 2023, closing a stake of 2,034 shares — an estimated $563K sold.

ETF Managers Group first reported a position in BIIB in Q2 2021 and held it in 5 quarters. The position peaked at $742K in Q2 2021. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • ETF Managers Group reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • ETF Managers Group sold 2,034 Biogen shares in Q1 2023, an estimated $563K.
  • ETF Managers Group first reported a position in Biogen in Q2 2021 and held it in 5 quarters.
  • ETF Managers Group's Biogen position peaked at $742K in Q2 2021.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.